Stock listing

BOATS:CELU Celularity Inc. Stock

US listing (BOATS) of Celularity Inc. · home listing NASDAQ:CELU

Follow Celularity Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CELU

$0.463 USD -0.020 (-4.2%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CELU

Past year -72.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.420 – $0.500 USDNov 20, 2026
Volume
295,913 sharesNov 20, 2026
Market cap
$15.02M USDAt the close on Nov 20, 2026 · price × 32.45M shares outstanding
52-week range
$0.420 – $2.550 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$7.85M USDMedian day 149,414 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Celularity Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CELU · Home$0.463 USD-0.020 (-4.2%)295,913$0.500$0.500$0.420$0.483Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CELU · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.463-0.020-4.2%$0.500$0.500$0.420295,913
$0.483-0.088-15.4%$0.580$0.720$0.465653,738
$0.571-0.048-7.8%$0.640$0.730$0.550229,541
$0.619-0.011-1.7%$0.630$0.630$0.597106,835
$0.630-0.055-8.0%$0.700$0.710$0.612138,784
$0.685-0.066-8.8%$0.767$0.800$0.650122,107
$0.751+0.040+5.6%$0.716$0.775$0.70166,301
$0.711-0.049-6.4%$0.750$0.763$0.705102,764
$0.7600.000-0.1%$0.751$0.800$0.720151,279
$0.760+0.035+4.8%$0.732$0.769$0.72460,564
$0.725-0.084-10.3%$0.800$0.820$0.721167,156
$0.809-0.008-1.0%$0.859$0.870$0.79972,008
$0.817+0.015+1.8%$0.808$0.900$0.79969,341
$0.803+0.002+0.3%$0.800$0.860$0.79098,822
$0.800-0.049-5.8%$0.820$0.869$0.800181,847
$0.849-0.091-9.7%$0.980$0.980$0.834496,839
$0.940+0.150+19.0%$0.821$1.040$0.782350,936
$0.790+0.040+5.4%$0.800$0.868$0.780219,290
$0.750-0.228-23.3%$0.964$1.000$0.660629,002
$0.978-0.072-6.9%$1.060$1.142$0.911145,347
$1.050+0.030+2.9%$1.070$1.080$1.010144,726
$1.020-0.240-19.0%$1.310$1.310$1.020204,708
$1.260+0.100+8.6%$1.160$1.300$1.16060,140
$1.160-0.090-7.2%$1.290$1.290$1.12187,785
$1.250-0.080-6.0%$1.330$1.330$1.22064,070
$1.330+0.020+1.5%$1.280$1.350$1.27030,651
$1.310-0.110-7.7%$1.390$1.410$1.28080,188
$1.420-0.050-3.4%$1.450$1.550$1.40050,371
$1.470-0.090-5.8%$1.560$1.570$1.46143,731
$1.560+0.100+6.8%$1.460$1.570$1.45153,197
$1.460-0.010-0.7%$1.460$1.500$1.430103,708
$1.470-0.110-7.0%$1.530$1.570$1.47068,941
$1.580-0.130-7.6%$1.700$1.769$1.540260,947
$1.710+0.110+6.9%$1.600$1.800$1.570282,127
$1.600+0.220+15.9%$1.370$1.635$1.360221,844
$1.380+0.030+2.2%$1.340$1.380$1.302142,148
$1.350-0.020-1.5%$1.370$1.370$1.28055,429
$1.370-0.030-2.1%$1.380$1.400$1.33439,646
$1.400+0.020+1.4%$1.400$1.460$1.350113,620
$1.380+0.060+4.5%$1.330$1.410$1.320166,069
$1.320+0.170+14.8%$1.170$1.350$1.170454,723
$1.150-0.030-2.5%$1.170$1.180$1.13077,117
$1.180-0.060-4.8%$1.220$1.260$1.160154,730
$1.240-0.070-5.3%$1.270$1.330$1.240214,037
$1.310+0.040+3.1%$1.280$1.350$1.220188,400
$1.270-0.020-1.6%$1.290$1.380$1.27077,758
$1.290+0.050+4.0%$1.260$1.389$1.210181,095
$1.240-0.160-11.4%$1.330$1.400$1.240149,414
$1.400-0.010-0.7%$1.320$1.430$1.310206,968
$1.410-0.025-1.7%$1.450$1.450$1.35197,105
$1.435-0.005-0.3%$1.405$1.480$1.385158,545
$1.440-0.100-6.5%$1.550$1.550$1.430148,745
$1.540-0.140-8.3%$1.700$1.734$1.520249,671
$1.680-0.150-8.2%$1.830$1.830$1.618351,362
$1.830-0.030-1.6%$1.850$1.894$1.780363,695
$1.860-0.020-1.1%$1.880$1.960$1.690654,741
$1.880+0.030+1.6%$1.860$2.070$1.7101,622,079
$1.850+0.270+17.1%$1.420$1.964$1.3803,422,193
$1.580-0.520-24.8%$2.145$2.200$1.48015,087,260
$2.100+1.220+138.5%$1.110$2.550$0.926221,052,891
$0.880+0.080+9.9%$0.806$0.976$0.780177,414
$0.801+0.026+3.4%$0.751$1.110$0.7511,184,841
$0.775-0.025-3.2%$0.775$0.860$0.74937,347
$0.800+0.033+4.3%$0.770$0.850$0.73126,346
$0.767-0.011-1.4%$0.701$0.820$0.70146,739

Splits

1 split · NASDAQ:CELU · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
BOATS:CELU
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Celularity Inc. news

Celularity Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
23 in the last 12 months · 121 in all · newest Oct 29, 2026 · oldest 2021
Decks
14 decks · latest February 2025

Where Celularity Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CELU · Home listingNASDAQUnited StatesUSD
BOATS:CELU · This pageBOATSUnited StatesUSD

Valuation

EV/sales 2.7× against a median of 4.8×: the lowest of 3 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$50.46M USD
P/E
Loss
EV/sales
2.7×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
−5.6%
Operating margin
−216.1%
Net margin
−117.3%
Debt to equity
Negative equity
Beta vs S&P 500
1.47

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Celularity Inc. · NASDAQ:CELUUS$15.02MUS$50.46Mn/a2.7×n/an/a−117.3%n/a1.47
MaaT Pharma · EURONEXT:MAATUS$16.11MUS$23.36Mn/a4.7×n/an/a−686.6%n/an/a
Elicera Therapeutics AB · OMXSTO:ELICUS$16.09MUS$10.40Mn/an/an/a2.9×n/a0.0×n/a
Pasithea Therapeutics Corp. · NASDAQ:KTTAUS$16.00M−US$25.22Mn/an/a−0.1×0.4×n/a0.0×0.97
Atossa Therapeutics, Inc. · NASDAQ:ATOSUS$15.92M−US$4.66Mn/an/an/a0.7×n/a0.0×0.87
Quoin Pharmaceuticals. Ltd · NASDAQ:QNRXUS$15.76M−US$17.43Mn/an/an/a0.6×n/a0.0×0.68
Context Therapeutics Inc. · NASDAQ:CNTXUS$14.70M−US$19.50Mn/an/an/a0.5×n/a0.0×0.99
NewcelX Ltd. · NASDAQ:NCELUS$14.67MUS$14.35Mn/an/an/a2.4×n/a0.1×0.89
Hepion Pharmaceuticals, Inc. · OTC:HEPAUS$14.63MUS$10.37Mn/an/an/an/an/an/a-1.02
Vectorite Biomedical, Inc. · TPEX:4170US$14.21MUS$9.16M4.9×4.9×n/a0.9×156.6%0.0×n/a
Estrella Immunopharma, Inc. · NASDAQ:ESLAUS$14.11MUS$14.01Mn/an/an/an/an/an/a1.31
Median of the othersUS$15.23MUS$9.77M4.9×4.8×−0.1×0.7×−265.0%0.0×0.89

Team and board

Officers

OfficerRole
Robert J. HaririChairperson, Founder, and CEO
Carlos RamirezSVP, Investor Relations
Rick GonzalezChief Commercial Officer

Board

DirectorRole
Robert J. HaririChairperson, Founder, and CEO
Diane ParksDirector
Geoffrey Shiu Fei LingDirector
Naveen JainDirector
Peter DiamandisDirector
Philip A. BarachDirector
Vincent LeVienDirector

Events

QuarterResultsShare move
Q3 2026Nov 20, 2026
Q2 2026Sep 29, 2026−3.6%
Q1 2026May 29, 2026+8.0%
Q3 2025Nov 14, 2025−4.4%
Q2 2025Aug 18, 2025 · After close−13.0%
Q1 2025May 8, 20250.0%
Q4 2024Feb 26, 2025−15.9%
Q3 2024Dec 31, 2024 · After close+5.8%
Q2 2024Aug 7, 2024−4.2%
Q1 2024May 14, 2024+14.5%
All 20 quarters
QuarterResultsShare move
Q4 2023Jan 2, 2024 · After close+0.5%
Q3 2023Dec 5, 2023 · Before open−3.4%
Q2 2023Aug 14, 2023 · After close−0.1%
Q1 2023May 22, 2023 · After close−2.3%
Q4 2022Mar 31, 2023 · After close+19.4%
Q3 2022Nov 10, 2022 · After close−4.7%
Q2 2022Aug 9, 2022 · After close+3.8%
Q1 2022May 16, 2022 · After close+17.8%
Q4 2021Mar 31, 2022 · After close+1.9%
Q3 2021Nov 12, 2021 · After close−4.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (February 2025)Investor deck28 slidesFebruary 2025
Investor Presentation (September 2024)Investor deck22 slidesSeptember 2024
Investor Day (May 2024)Investor day59 slidesMay 21, 2024
Investor Presentation (June 2023)Investor deck14 slidesJune 2023
Investor Presentation (June 2022)Investor deck34 slidesJune 2022
Investor Presentation (June 2022)Investor deck33 slidesJune 2022
Investor Presentation (May 2022)Investor deck28 slidesMay 2022
Corporate Update (December 2021)Corporate update16 slidesDec 17, 2021
Investor Presentation (October 2021)Investor deck44 slidesOctober 2021
Investor Presentation (October 2021)Investor deck44 slidesOctober 2021
All 14 decks
DeckKindSlidesDate
Investor Presentation (July 2021)Investor deck51 slidesJuly 2021
GX Acquisition — SPAC Merger (April 2021)SPAC merger51 slidesApr 28, 2021
GX Acquisition — SPAC Merger (February 2021)SPAC merger55 slidesFeb 11, 2021
SPAC Merger (January 2021)SPAC merger54 slidesJan 8, 2021

Open Decks

Financings

RaiseDate
Private placement of senior secured convertible notes and warrants
Tranche closed: US$10M raised · Warrants at US$1.5 for 60 months · Odeon Capital Group LLC
Dealers: Odeon Capital Group LLC (lead)
Buyers: Philip A. Barach
Use of proceeds: Support commercial execution and manufacturing expansion
Sep 24, 2026
Senior secured term loan with warrants
Announced: US$7M · Warrants at US$2
Buyers: Philip A. Barach
Use of proceeds: Support strategic priorities around longevity and preservation of human performance
Dec 18, 2025
Secured convertible notes
Announced: up to US$5M · Warrants at US$2
Buyers: Philip A. Barach
Use of proceeds: Support strategic priorities around longevity and preservation of human performance
Dec 18, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as GX Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on May 20, 2019.

Price
US$10.00 a unit
Units offered
25,000,000 units
Offering size
US$250 million
Underwriters' option
Up to 3,750,000 more units
Listing
GXGXU on the Nasdaq Capital Market
Underwriter
Cantor
Units delivered
On or about May 23, 2019

Steps

StepWhen
Draft sent to the SEC in confidenceNov 5, 2018
Filed publiclyApr 26, 2019
Amended onceMay 13, 2019
Shares registered with an exchangeMay 17, 2019
Declared effective by the SECMay 20, 2019
Final prospectus, with the priceMay 21, 2019

Open IPO · From the cover of the final prospectus (424B4) filed May 21, 2019

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue26.6M54.2M22.8M18.0M21.3M14.3M21.1M17.6M
Cost of revenue20.1M15.0M16.0M19.7M9.65M4.93M6.32M6.55M
Gross profit6.48M39.2M6.75M-1.69M11.7M9.35M14.8M11.0M
Research and development15.0M17.4M30.5M78.4M88.4M52.7M46.1M29.1M
Selling, general and administrative51.3M58.6M50.6M66.0M71.3M31.3M40.6M
Operating income-61.3M-38.4M-192.3M-25.6M-109.1M-151.9M-1.68M-1.10K
Depreciation and amortization7.29M7.92M9.32M9.44M8.82M8.17M6.19M4.79M
EBITDA-54.0M-30.4M-183.0M-16.2M-100.2M-143.8M4.50M4.79M
Interest expense6.75M6.26M3.02M3.17M3.17M2.35M3.75M0
Income before tax-91.7M-57.9M-196.3M14.2M-100.1M-212.9M6.55M-1.10K
Income tax3.00K10.0K10.0K13.0K20.0K-4.70M668.2K21.3M
Net income-91.7M-57.9M-196.3M14.2M-100.1M-208.2M5.88M-1.10K
Earnings per share, basic-3.59-2.64-11.021.01-1.49-11.310.10-0.00
Earnings per share, diluted-3.59-2.64-11.020.95-1.49-11.310.10

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents6.17M738.0K227.0K14.0M37.2M54.3M917.0K24.7K
Receivables4.65M13.6M10.0M6.97M5.23M6.55M3.08M3.92M
Inventory571.0K5.41M5.75M5.31M9.55M9.55M3.23M3.54M
Current assets12.3M20.6M19.8M33.5M59.1M72.2M1.01M24.7K
Property, plant and equipment55.8M61.6M67.8M75.7M90.6M90.1M66.4M4.01M
Goodwill7.35M7.35M7.35M119.7M123.3M123.3M127.1M130.6M
Total assets107.3M132.7M143.9M401.1M414.1M431.0M291.6M24.7K
Accounts payable26.4M23.3M14.1M5.81M9.32M5.39M18.9K5.27M
Current liabilities80.8M53.7M67.3M62.1M26.2M26.7M229.1K150.6K
Long-term debt33.8M35.9M
Total debt40.9M68.8M65.6M31.1M30.6M28.1M150.0K
Total liabilities145.4M123.8M102.9M202.2M314.7M412.3M28.2M150.6K
Shareholders' equity-38.1M8.84M41.0M198.9M99.4M-531.4M-327.4M-125.8K
Shares outstanding28.8M22.5M19.4M14.9M124.3M18.5M3.17M3.59M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-13.3M-6.40M-38.7M-137.9M-110.1M-63.2M-1.10M-543
Capital spending0-161.0K-1.05M-5.24M-6.20M-27.8M-3-1.92M
Free cash flow-13.3M-6.56M-39.7M-143.1M-116.3M-91.0M-1.10M-1.92M
Cash from investing514.0K-4.05M-5.24M-5.90M-12.8M-286.8M-31.2M
Cash from financing18.6M6.70M24.1M119.8M98.6M102.0M288.8M25.3K
Dividends paid-5.90M0-39.1M
Share buybacks-132.0K0-256.0K6.49M
Change in cash5.39M814.0K-18.6M-23.3M-17.4M26.0M892.3K-31.2M

Open Financials

Filings

FilingDateTypeFiled with
NT 10-Q · Late filing noticeNov 16, 2026Explanation requestSEC
ARS · Annual report to shareholdersNov 10, 2026Annual reportSEC
DEFA14A · Additional proxy materialNov 10, 2026Meeting noticeSEC
DEF 14A · Proxy statementNov 10, 2026Meeting noticeSEC
8-K · Current reportOct 29, 2026Current reportSEC
PRE 14A · Preliminary proxy statementOct 28, 2026Meeting noticeSEC
10-Q · Quarterly reportOct 20, 2026Quarterly reportSEC
10-K/A · Annual report, amendedOct 20, 2026Annual reportSEC
8-K · Current reportSep 29, 2026Management or board changeSEC
10-Q · Quarterly reportSep 29, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13D/A · Big-stake notice, amendedSep 28, 2026Big-stake noticeSEC
8-K · Current reportSep 28, 2026Material contractSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
8-K · Current reportSep 14, 2026Current reportSEC
NT 10-Q · Late filing noticeAug 14, 2026Explanation requestSEC
8-K · Current reportAug 7, 2026Management or board changeSEC
8-K · Current reportJul 29, 2026Current reportSEC
25-NSEJul 22, 2026Other filingsSEC
8-K · Current reportJun 30, 2026Material contractSEC
8-K · Current reportJun 25, 2026Management or board changeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 23, 2026Big-stake noticeSEC
8-K · Current reportJun 12, 2026Current reportSEC
8-K · Current reportJun 3, 2026Management or board changeSEC
8-K · Current reportMay 28, 2026Material contractSEC
NT 10-Q · Late filing noticeMay 15, 2026Explanation requestSEC
10-K · Annual reportApr 30, 2026Annual reportSEC
3 · Initial statement of ownershipApr 24, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 24, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 24, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 22, 2026Big-stake noticeSEC
8-K · Current reportApr 21, 2026Material contractSEC
4 · Change in ownershipApr 15, 2026Insider tradeSEC
4 · Change in ownershipApr 15, 2026Insider tradeSEC
4 · Change in ownershipApr 15, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeApr 3, 2026Big-stake noticeSEC
NT 10-K · Late filing noticeMar 31, 2026Explanation requestSEC
8-K · Current reportMar 10, 2026Material contractSEC
8-K · Current reportMar 5, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2026Big-stake noticeSEC
8-K · Current reportJan 21, 2026Management or board changeSEC
4/A · Change in ownership, amendedJan 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJan 15, 2026Insider tradeSEC
4 · Change in ownershipJan 14, 2026Insider tradeSEC
4 · Change in ownershipJan 14, 2026Insider tradeSEC
4 · Change in ownershipJan 14, 2026Insider tradeSEC
4 · Change in ownershipJan 14, 2026Insider tradeSEC
424B3 · ProspectusJan 8, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 8, 2026Other filingsSEC
CORRESP · Letter to the SECJan 5, 2026Other filingsSEC
UPLOAD · Letter from the SECJan 5, 2026Other filingsSEC
S-1 · Registration statementDec 31, 2025Offer documentSEC
4 · Change in ownershipDec 30, 2025Insider tradeSEC
4 · Change in ownershipDec 30, 2025Insider tradeSEC
4 · Change in ownershipDec 30, 2025Insider tradeSEC
4 · Change in ownershipDec 30, 2025Insider tradeSEC
424B3 · ProspectusDec 30, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 30, 2025Other filingsSEC
CORRESP · Letter to the SECDec 23, 2025Other filingsSEC
8-K · Current reportDec 23, 2025Material contractSEC
UPLOAD · Letter from the SECDec 23, 2025Other filingsSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
S-1 · Registration statementDec 19, 2025Offer documentSEC
8-K · Current reportDec 19, 2025Meeting outcomeSEC
8-K · Current reportDec 5, 2025Current reportSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
S-8 · Registration statement for employee plansNov 7, 2025Offer documentSEC
DEFA14A · Additional proxy materialNov 7, 2025Meeting noticeSEC
ARS · Annual report to shareholdersNov 7, 2025Annual reportSEC
DEF 14A · Proxy statementNov 7, 2025Meeting noticeSEC
DNov 3, 2025Other filingsSEC
8-K · Current reportOct 28, 2025Material contractSEC
8-K · Current reportSep 2, 2025Current reportSEC
10-Q · Quarterly reportAug 29, 2025Quarterly reportSEC
10-Q · Quarterly reportAug 29, 2025Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeAug 27, 2025Big-stake noticeSEC
8-K · Current reportAug 18, 2025Material contractSEC
8-K · Current reportAug 12, 2025Material contractSEC
DAug 5, 2025Other filingsSEC
DAug 5, 2025Other filingsSEC
DAug 5, 2025Other filingsSEC
8-K · Current reportAug 1, 2025Material contractSEC
8-K · Current reportJul 30, 2025Material contractSEC
8-K/A · Current report, amendedJul 29, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 28, 2025Big-stake noticeSEC
4 · Change in ownershipJul 28, 2025Insider tradeSEC
4 · Change in ownershipJul 28, 2025Insider tradeSEC
8-K · Current reportJul 22, 2025Material contractSEC
3 · Initial statement of ownershipJul 16, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 10, 2025Insider tradeSEC
8-K · Current reportJun 10, 2025Management or board changeSEC
8-K · Current reportJun 6, 2025Management or board changeSEC
4/A · Change in ownership, amendedJun 4, 2025Insider tradeSEC
10-K/A · Annual report, amendedMay 21, 2025Annual reportSEC
8-K · Current reportMay 20, 2025Material contractSEC
8-K · Current reportMay 16, 2025Management or board changeSEC
8-K · Current reportMay 9, 2025ResultsSEC
10-K · Annual reportMay 8, 2025Annual reportSEC
8-K · Current reportMay 1, 2025Current reportSEC
8-K · Current reportApr 23, 2025Current reportSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
NT 10-K · Late filing noticeMar 31, 2025Explanation requestSEC
8-K · Current reportMar 21, 2025Material contractSEC
RW · Request to withdraw a registrationMar 10, 2025Other filingsSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
8-K · Current reportFeb 24, 2025Current reportSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
8-K · Current reportFeb 18, 2025Material contractSEC
EFFECT · Notice that a registration is effectiveFeb 18, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
CORRESP · Letter to the SECFeb 13, 2025Other filingsSEC
CORRESP · Letter to the SECFeb 13, 2025Other filingsSEC
FWP · Free writing prospectusFeb 13, 2025Offer documentSEC
S-1/A · Registration statement, amendedFeb 13, 2025Offer documentSEC
UPLOAD · Letter from the SECFeb 6, 2025Other filingsSEC
S-1 · Registration statementJan 30, 2025Offer documentSEC
4 · Change in ownershipJan 28, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 28, 2025Big-stake noticeSEC
8-K · Current reportJan 27, 2025Material contractSEC
8-K · Current reportJan 24, 2025Current reportSEC
4 · Change in ownershipJan 7, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
8-K · Current reportJan 3, 2025Material contractSEC
8-K · Current reportDec 20, 2024Meeting outcomeSEC
3 · Initial statement of ownershipDec 19, 2024Insider tradeSEC
4 · Change in ownershipDec 19, 2024Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 19, 2024Big-stake noticeSEC
10-Q · Quarterly reportDec 5, 2024Quarterly reportSEC
8-K · Current reportDec 2, 2024Material contractSEC
8-K · Current reportNov 27, 2024Current reportSEC
DEF 14A · Proxy statementNov 19, 2024Meeting noticeSEC
NT 10-Q · Late filing noticeNov 15, 2024Explanation requestSEC
8-K · Current reportNov 8, 2024Current reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
8-K · Current reportOct 25, 2024ResultsSEC
8-K · Current reportOct 21, 2024Current reportSEC
10-Q · Quarterly reportOct 16, 2024Quarterly reportSEC
8-K · Current reportOct 16, 2024Material contractSEC
8-K · Current reportSep 13, 2024Management or board changeSEC
4 · Change in ownershipAug 28, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 28, 2024Insider tradeSEC
8-K · Current reportAug 28, 2024Management or board changeSEC
8-K · Current reportAug 23, 2024Current reportSEC
NT 10-Q · Late filing noticeAug 16, 2024Explanation requestSEC
8-K · Current reportAug 5, 2024Management or board changeSEC
10-K · Annual reportJul 30, 2024Annual reportSEC
8-K · Current reportMay 24, 2024Current reportSEC
8-K · Current reportMay 21, 2024ResultsSEC
NT 10-Q · Late filing noticeMay 15, 2024Explanation requestSEC
8-K · Current reportApr 22, 2024Current reportSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
4 · Change in ownershipApr 16, 2024Insider tradeSEC
NT 10-K · Late filing noticeApr 1, 2024Explanation requestSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMar 15, 2024Big-stake noticeSEC
8-K · Current reportMar 15, 2024Material contractSEC
8-K · Current reportFeb 26, 2024Meeting outcomeSEC
8-K · Current reportFeb 22, 2024Management or board changeSEC
4 · Change in ownershipFeb 21, 2024Insider tradeSEC
4 · Change in ownershipFeb 21, 2024Insider tradeSEC
4 · Change in ownershipFeb 21, 2024Insider tradeSEC
4 · Change in ownershipFeb 21, 2024Insider tradeSEC
4 · Change in ownershipFeb 21, 2024Insider tradeSEC
4 · Change in ownershipFeb 21, 2024Insider tradeSEC
8-K · Current reportFeb 12, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 8, 2024Big-stake noticeSEC
DEF 14A · Proxy statementFeb 2, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementJan 23, 2024Meeting noticeSEC
4 · Change in ownershipJan 17, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJan 17, 2024Big-stake noticeSEC
8-K · Current reportJan 17, 2024Material contractSEC
8-K · Current reportJan 9, 2024ResultsSEC
10-Q · Quarterly reportJan 2, 2024Quarterly reportSEC
8-K · Current reportDec 29, 2023Management or board changeSEC
8-K · Current reportNov 24, 2023Current reportSEC

This page holds 200 of 564 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Celularity Inc.’s releases · as of Sep 30, 2026

Common shares
32,449,891
Fully diluted
32,449,891

Fully diluted

LineSharesAs of
Common shares32,449,891Sep 30, 2026

Warrants and options

Lot
Warrants · US$1.50 · expire about Sep 2031

Share count over time

CountShares
Sep 30, 202632,449,891

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard770K2.4%US$1.04MSep 30, 2026
C V Starr & Co Inc764K2.4%US$1.03MSep 30, 2026
Geode Capital167K0.52%US$226KSep 30, 2026
UBS80,0750.25%US$108KSep 30, 2026
BlackRock76,3590.24%US$103KSep 30, 2026
State Street57,8300.18%US$78,071Sep 30, 2026
Northern Trust49,8740.15%US$67,330Sep 30, 2026
Biltmore Family Office, LLC35,0000.11%US$47,250Sep 30, 2026
HB Wealth Management, LLC31,9150.10%US$43,085Sep 30, 2026
Sky Investment Group LLC29,9200.09%US$40,392Sep 30, 2026
All 31 holders
HolderSharesOf the companyValueAs of
RBC18,0000.06%US$24,000Sep 30, 2026
Jane Street17,4030.05%US$23,494Sep 30, 2026
IPG Investment Advisors LLC17,1690.05%US$23,178Sep 30, 2026
Mercer Global Advisors Inc15,2000.05%US$20,520Sep 30, 2026
BFC Planning, Inc.7,7130.02%US$10,413Sep 30, 2026
Tower Research Capital LLC (TRC)3,3230.01%US$4,486Sep 30, 2026
Wells Fargo2,500<0.01%US$3,375Sep 30, 2026
SBI Securities Co., Ltd.1,882<0.01%US$2,541Sep 30, 2026
Caldwell Sutter Capital, Inc.1,000<0.01%US$1,350Sep 30, 2026
CoreCap Advisors, LLC500<0.01%US$675Sep 30, 2026
HighMark Wealth Management LLC441<0.01%US$595Sep 30, 2026
Global Retirement Partners, LLC300<0.01%US$405Sep 30, 2026
Financial Perspectives, Inc171<0.01%US$231Sep 30, 2026
Valley National Advisers Inc100<0.01%US$135Sep 30, 2026
BNP Paribas99<0.01%US$134Sep 30, 2026
Jones Financial Companies Lllp82<0.01%US$113Sep 30, 2026
United Financial Planning Group LLC19<0.01%US$26Sep 30, 2026
JPMorgan16<0.01%US$22Sep 30, 2026
Harbour Investments, Inc.15<0.01%US$20Sep 30, 2026
Barclays4<0.01%US$5Sep 30, 2026
Danske Bank A/S1<0.01%US$1Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund455K1.4%US$272KJun 30, 2026
Vanguard Extended Market Index Fund166K0.51%US$99,285Jun 30, 2026
Fidelity Extended Market Index Fund105K0.32%US$106KMay 31, 2026
Fidelity Series Total Market Index Fund21,1760.07%US$21,388May 31, 2026
Fidelity Total Market Index Fund20,6770.06%US$20,884May 31, 2026
Fidelity Nasdaq Composite Index Fund8,4380.03%US$8,522May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Lim Kok Thay41.00%14.1MJul 24, 2025Schedule 13D
PHILIP & DANIELE BARACH FAMILY TRUST29.00%11.9MSep 23, 2026Schedule 13D
Dragasac Ltd26.80%6.34MJan 24, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robin L. Smith
Other companies: Matinas BioPharma Holdings, Inc. (Director · Feb 13, 2025 – Nov 4, 2026 · Past); Cycurion, Inc. (Director · Jan 11, 2022 – Jan 11, 2022 · Past); ServiceSource International Inc (Director · Feb 27, 2020 – May 20, 2020 · Past); Sorrento Therapeutics, Inc. (Director · Dec 16, 2019 – Sep 3, 2021 · Past); Rockwell Medical, Inc. (Director · Jun 6, 2019 – Jun 6, 2019 · Past); Emmaus Life Sciences, Inc. (Director · May 8, 2019 – May 8, 2019 · Past)
Director · Jul 16, 2021 – Jun 14, 2023 · Past
Andrew C Von Eschenbach
Other companies: Bausch + Lomb Corporation (Director · Since at least May 5, 2022); TriSalus Life Sciences, Inc. (Director · Aug 10, 2023 – Aug 13, 2024 · Past); Radius Health, Inc. (Director · Aug 15, 2022 – Aug 15, 2022 · Past)
Director · Jul 13, 2022 – Jun 14, 2023 · Past
Dean Kehler
Other companies: NioCorp Developments Ltd. (Director · Since at least Mar 17, 2023); BCP Investment Corporation (Independent Director · Since at least Feb 29, 2012); El Pollo Loco Holdings, Inc. (Director · Jul 24, 2014 – Aug 31, 2022 · Past)
Director · May 20, 2019 – Dec 19, 2024 · Past
John Sculley
Other companies: Zeta Global Holdings Corp. (Director · Jun 9, 2021 – Jun 9, 2025 · Past); Kaleido Biosciences, Inc. (Director · Feb 27, 2019 – Feb 27, 2019 · Past); Decoy Therapeutics Inc. (Director · Jan 28, 2015 – Jun 8, 2016 · Past)
Director · Jul 16, 2021 – Jun 14, 2023 · Past
Marc Mazur
Other companies: Soren Acquisition Corp. (Independent Director · Since at least Jan 6, 2026); SuRo Capital Corp. (Director · Since at least Jul 2, 2020); Fibrocell Science Inc (Director · Jun 22, 2016 – Dec 13, 2019 · Past)
Director · May 20, 2019 – Jun 14, 2023 · Past
Peter Diamandis
Other companies: Vaxxinity, Inc. (Director · Nov 10, 2021 – Jun 20, 2023 · Past); DPCM Capital Inc (Director · Oct 20, 2020 – Aug 5, 2022 · Past); CuriosityStream Inc. (Director · Nov 19, 2019 – Nov 19, 2019 · Past)
Director · Since at least Jul 16, 2021
Geoffrey M D Ling
Other companies: Gyre Therapeutics, Inc. (Director · Jan 15, 2020 – Jan 7, 2022 · Past)
Director · Since at least Aug 31, 2023
Michael Maselli
Other companies: NioCorp Developments Ltd. (Director · Since at least Mar 17, 2023)
Vice President of Acquisitions · May 20, 2019 – May 20, 2019 · Past
Robert J. Hariri
Other companies: CryoPort, Inc. (Chairman of the Scientific and Technology Committee · Since at least May 28, 2025)
Chairperson, Founder, and CEO · Since at least Apr 13, 2025
Andrea J KellettChief Financial Officer · May 20, 2019 – May 20, 2019 · Past
All 25 people
PersonSeat
Anne JonesChief Business Officer · Jul 16, 2021 – Jul 13, 2022 · Past
Bradley GloverSee Remarks · Jul 16, 2021 – Apr 13, 2023 · Past
Carlos RamirezSVP, Investor Relations · Since at least Jun 3, 2026
David C BeersChief Financial Officer · Apr 13, 2025 – Apr 13, 2025 · Past
Diane ParksDirector · Since at least Nov 5, 2026
Geoffrey Shiu Fei LingDirector · Since at least Nov 5, 2026
Hillel WeinbergerDirector · May 20, 2019 – May 20, 2019 · Past
John R HainesSenior Exec Vice President · Since at least Jul 16, 2021
Joseph DosSantosInterim CFO · Since at least Jun 10, 2025
Kyle FletcherSee Remarks · Jul 13, 2022 – Apr 13, 2024 · Past
Naveen JainDirector · Since at least Sep 29, 2026
Philip A. BarachDirector · Since at least Sep 24, 2026
Rick GonzalezChief Commercial Officer · Since at least Jun 3, 2026
Stephen BrigidoPres., Functional Regeneration · Since at least Jul 16, 2021
Vincent LeVienDirector · Since at least Jun 5, 2025

Open People

Log in to ask 6ix AI your own questions about Celularity Inc.